Alkermes wins FDA Breakthrough Therapy status for alixorexton in NT1 after Vibrance-1 data shows improvement in wakefulness.

In obstructive sleep apnea, using CPAP therapy more than 4 hours a night sharply cuts residual sleepiness and lowers crash ...

Artificial intelligence can use brain recordings from a single night in a sleep lab to predict a person's risk of developing ...

An evidence-based web-app helped children with epilepsy to fall asleep on average 16.5 minutes earlier. A new UK-wide ...

Medical News Today looks at three key studies and their key findings that highlight and further confirm the connection between how poor sleep increases dementia risk.

SleepFM showed especially strong results for Parkinson’s disease (C-index 0.89), dementia (0.85), hypertensive heart disease ...

A poor night's sleep portends a bleary-eyed next day, but it could also hint at diseases that will strike years down the road ...

Supplements may negatively affect sleep quality due to their ingredients, mode of action, or the timing of doses. Some vitamins, such as melatonin, promote relaxation and induce sleep. Others can act ...

Sleep and satisfaction with social support mediated the relationship between adverse childhood experiences and depressive ...

The FDA has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1).

A poor night's sleep portends a bleary-eyed next day, but it could also hint at diseases that will strike years down the road ...

Corin Cesaric is a Flex Editor at CNET. She received her bachelor's degree in journalism from the University of Missouri-Columbia. Before joining CNET, she covered crime at People Magazine and ...